IMARA Inc. (IMRA) is increasing by 8% in premarket – Learn more!
IMARA Inc. (IMRA) experienced an increase of 8% in the premarket after the clearance of tovinontrine application by the FDA. However, the last trading session concluded at $1.5 with a decrease of 4.46%. Clearance of tovinontrine application – What’s New? On 25th January 2022, IMRA announced that FDA has approved the application for tovinontrine drug. …
IMARA Inc. (IMRA) is increasing by 8% in premarket – Learn more! Read More »